Yıl: 2021 Cilt: 10 Sayı: 3 Sayfa Aralığı: 203 - 212 Metin Dili: Türkçe DOI: 10.5505/ktd.2021.26234 İndeks Tarihi: 21-05-2022

Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center

Öz:
INTRODUCTION: Hemophilia-specific quality of life index (Haemo-QoL) is a questionnaire designed for patients with hemophilia. It is a valuable tool to evaluate standards of care and to understand patient's and parent's feelings and challenges. This study aims to evaluate the quality of life in hemophiliac patients. METHODS: Hemophilia patients 4-25-year-old and having factor level ≤1 were enrolled during their outpatient visits. Turkish version of Haemo-QoL for children and proxy and adults was applied. (www.haemoqol.de) Patients were also screened for hepatitis virus and human immune deficiency virus serology. RESULTS: Forty-three patients with hemophilia A and hemophilia B were enrolled. The study group was 74.1% of the patients carrying enrolment criteria. The median age of diagnosis was 11.5 (5.5-25.5) months for the 4-16 age group and 12.0(6.0-27.0) months for the 17-25-year-old group. Sixty percent of the patients (26/43) could perform the home treatment. Patients on primary prophylaxis and secondary prophylaxis were18.60% and 69.76% of the study group, respectively. Two patients in the>16 age group were hepatitis B carriers. Factor injection was the most impaired score in the 4-16-year-old group. In the 4-7-year-old group, relations with family and treatment dimensions were poorly impaired. In the 8-12 age group perceived support and in the 13-16 age group, sports and leisure scores were poor. In 4-16-year-old groups total haemo-QoL score range was 29.9-34.4. There was no patient with severe arthropathy DISCUSSION AND CONCLUSION: Quality of life of children and young adults with hemophilia is acceptable in this study. Training of the patients and families should continue for more compliance to prophylaxis.
Anahtar Kelime:

-

Öz:
GİRİŞ ve AMAÇ: Hemofiliye özgü hayat kalitesi ölçeği hemofili hastaları için düzenlenmiş bir ankettir. Hemofili tedavi standartlarını, hasta ve ebeveynlerinin duygularını ve yaşadıkları güçlükleri değerlendirmek için değerli bir araçtır. Bu çalışmanın amacı hemofili hastası çocuk ve genç erişkinlerin hayat kalitesini değerlendirmektir. YÖNTEM ve GEREÇLER: Faktör düzeyi <1 olan 4-25 yaştaki hemofili hastaları poliklinik başvuruları sırasında çalışmaya alındı. Hemofiliye özgü yaşam kalitesi anketi çocuklar ve vasilerine (Haemo-QoL) ve erişkin hastalara (Haemo-A-QoL) uygulandı. (www.haemoqol.de). Hepatit ve insan immün yetersizlik virusu serolojisi için taramaları da yapıldı. BULGULAR: Hemofili A ve hemofili B tanılı 43 hasta çalışmaya alındı. Çalışma grubu dahil etme kriterlerine sahip hastaların %74,1 ini oluşturuyordu. Tanıda ortanca yaş 4-16 yaştaki hastalarda 11,5 (5,5-25,5) ay, 17-25 yaştakilerde 12,0(6,0-27,0) aydı. Hastaların %60 ı (26/43) evde tedavi uygulayabiliyordu. Birincil ve ikincil koruyucu tedavi uygulayanlar sırasıyla grubun %18,6 ve 69,7 sini oluşturuyordu. On altı yaş üstündeki iki hasta hepatit B taşıyıcısıydı. Faktör enjeksiyonu 4-16 yaş grubunda en kötü puanı aldı. 4-7 yaş grubunda aile ilişkiler ve tedavi kötü etkilenmişti. 8-12 yaş grubunda algılanan destek, 13-16 yaş grubunda spor ve boş zamanlar kötü etkilenmişti. 4-16 yaş gruplarında toplam Haemo-QoL puanı 29,9-34,4 arasındaydı. Ağır eklem sorunu olan hasta yoktu. TARTIŞMA ve SONUÇ: Bu çalışmada hemofili hastası çocuk ve genç erişkinlerin hayat kalitesi kabul edilebilir düzeydeydi. Profilaksiye uyumu arttırmak için hasta ve ailelerin eğitimi sürdürülmelidir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Gringeri A, von Mackensen S, Auerswald G, Bullinger M , Perez Garrido R , Kellermann E, et al. Haemo-QoL Study. Health status and health-related quality of life of children with hemophilia from six West European countries. Haemophilia 2004; 10 Suppl 1: 26-33.
  • 2. Mercan A, Sarper N, Inanir M, Mercan HI, Zengin E, Kilic SC, et al. Hemophilia-Specific Quality of Life Index (Haemo-QoL and Haem-A-QoL questionnaires) of children and adults: a result of a single-center from Turkey. Pediatr Hematol Oncol 2010; 27: 449-61.
  • 3. Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, et al. Intracranial hemorrhage in children and adolescents with severe hemophilia A or B - the impact of prophylactic treatment. Br J Haematol 2017; 179: 298-307.
  • 4. Ay Y, Toret E, Oymak Y, Hilkay Karpınar T, İnce D, Özek G et al. Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country. Coagulation & Fibrinolysis 2016; 27:729-31.
  • 5. Ünüvar A, Kavaklı K, Baytan B, Kazancı E, Saylı T, Oren H et al. Low-dose immune tolerance induction for pediatric hemophilia patients with factor VIII inhibitors. Haemophilia 2008;14:315-22.
  • 6. Ugur MC, Kavaklı K. Prospective Evaluation of the Non-Compliant Severe Hemophilia Patients. Letter. Turk J Haematol 2018; doi: 10.4274/tjh.2018.0281.
  • 7. von Mackensen S, Shah J, Seifert W, Kenet G. Health-related quality of life in pediatric hemophilia B patients treated with Rix-FP. Haemophilia 2018; doi:10.1111/hae. 13618.
  • 8. Oldenburg J, Mahlangu JN, Bujan W, Trask P, Callaghan MU, Young G, et al. The effect of emicizumab prophylaxis on health-related outcomes in persons with hemophilia A with inhibitors: HAVEN 1 Study. Haemophilia 2018; 14. doi: 10.1111/hae.13618.
  • 9. von Mackensen S, Myrin Westesson L, Kavakli K, Klukowska A, Escuriola C, Uitslager N et al. The impact of psychosocial determinants on caregivers' burden of children with hemophilia (results of the BBC study). Haemophilia. 2019;25:424-32 10. Pinto PR, Paredes AC, Moreira P, Fernandes S, Lopes M, Carvalho M, et al. Emotional distress in hemophilia: Factors associated with the presence of anxiety and depression symptoms among adults. Haemophilia 2018; 24:e344-e353. doi: 10.1111/hae.13548.
  • 11. Limberg PF, Haverman L, Beijlevelt M, van der Pot M, Zaal G, de Boer WA, et al. Psychosocial care for children with hemophilia and their parents in the Netherlands. Review. Haemophilia 2017; 23: 362-69.
  • 12. O'Hara J, Sima CS, Frimpter J, Paliargues F, Chu P, Presch I. Long-term outcomes from prophylactic or episodic treatment of hemophilia A: A systematic review. Haemophilia 2018; 24:e301-e311. doi: 10.1111/hae.13546.Review.
  • 13. Z Kaya, N Ismayilova, C Muluk, M Albayrak, Güney E, Aytaç S, et al. Prophylaxis adherence relative to the quality of life and anxiety level in Turish patients with severe hemophilia A. HemaSphere: June 2019 - Volume 3 - Issue S1 - p 1017
APA deniz a, Sarper N, zengin e, AYLAN GELEN S (2021). Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. , 203 - 212. 10.5505/ktd.2021.26234
Chicago deniz adnan,Sarper Nazan,zengin emine,AYLAN GELEN SEMA Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. (2021): 203 - 212. 10.5505/ktd.2021.26234
MLA deniz adnan,Sarper Nazan,zengin emine,AYLAN GELEN SEMA Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. , 2021, ss.203 - 212. 10.5505/ktd.2021.26234
AMA deniz a,Sarper N,zengin e,AYLAN GELEN S Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. . 2021; 203 - 212. 10.5505/ktd.2021.26234
Vancouver deniz a,Sarper N,zengin e,AYLAN GELEN S Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. . 2021; 203 - 212. 10.5505/ktd.2021.26234
IEEE deniz a,Sarper N,zengin e,AYLAN GELEN S "Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center." , ss.203 - 212, 2021. 10.5505/ktd.2021.26234
ISNAD deniz, adnan vd. "Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center". (2021), 203-212. https://doi.org/10.5505/ktd.2021.26234
APA deniz a, Sarper N, zengin e, AYLAN GELEN S (2021). Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. Kocaeli Tıp Dergisi, 10(3), 203 - 212. 10.5505/ktd.2021.26234
Chicago deniz adnan,Sarper Nazan,zengin emine,AYLAN GELEN SEMA Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. Kocaeli Tıp Dergisi 10, no.3 (2021): 203 - 212. 10.5505/ktd.2021.26234
MLA deniz adnan,Sarper Nazan,zengin emine,AYLAN GELEN SEMA Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. Kocaeli Tıp Dergisi, vol.10, no.3, 2021, ss.203 - 212. 10.5505/ktd.2021.26234
AMA deniz a,Sarper N,zengin e,AYLAN GELEN S Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. Kocaeli Tıp Dergisi. 2021; 10(3): 203 - 212. 10.5505/ktd.2021.26234
Vancouver deniz a,Sarper N,zengin e,AYLAN GELEN S Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center. Kocaeli Tıp Dergisi. 2021; 10(3): 203 - 212. 10.5505/ktd.2021.26234
IEEE deniz a,Sarper N,zengin e,AYLAN GELEN S "Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center." Kocaeli Tıp Dergisi, 10, ss.203 - 212, 2021. 10.5505/ktd.2021.26234
ISNAD deniz, adnan vd. "Hemophilia Specific Quality of Life Index in Turkish Children and Young Adults. Cross-sectional Study from a Single Center". Kocaeli Tıp Dergisi 10/3 (2021), 203-212. https://doi.org/10.5505/ktd.2021.26234